Semantic Scholar uses AI to extract papers important to this topic.
AT-1015 is a novel selective 5-HT2A serotonin receptor antagonist that is known to impair platelet aggregation and… Expand OBJECTIVE
The effect of AT-1015, a serotonin(2A) receptor antagonist, on the resaturation of ischemic muscle in a… Expand OBJECTIVE
To assess the safety of AT-1015 in combination with high-dose aspirin (300 mg daily). Study subjects were 17 healthy… Expand The purpose of this study was to examine the inhibitory effects of AT‐1015, a newly synthesized 5‐HT2 receptor antagonist, on… Expand The purpose of this study was to investigate the association and dissociation kinetics of [3H]AT‐1015 from 5‐HT2 receptors in… Expand The antithrombotic activity of N-[2-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino)ethyl]-1-formyl-4-piperidinecarboxamide… Expand This study investigated the binding affinities of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d… Expand The object of this study was to investigate the binding affinity of a newly synthesized 5-HT2 antagonist, (N-[2-[4-(5H-dibenzo[a… Expand The serotonin (5-HT2A) antagonistic activities and the protective effect on laurate-induced peripheral vascular lesions of AT… Expand Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene… Expand